NYSE:MDC - M.D.C. Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$28.10 +0.23 (+0.83 %)
(As of 12/11/2018 11:43 AM ET)
Previous Close$27.87
Today's Range$28.10 - $28.34
52-Week Range$25.14 - $35.18
Volume1,435 shs
Average Volume437,963 shs
Market Capitalization$1.63 billion
P/E Ratio10.97
Dividend Yield4.17%
M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, Washington, Colorado, Utah, Virginia, Florida, Maryland, Pennsylvania, and New Jersey. Its financial services operations consist of originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. M.D.C. Holdings, Inc. was founded in 1972 and is based in Denver, Colorado.

Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for MDC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Operative builders
Current SymbolNYSE:MDC
Previous Symbol


Debt-to-Equity Ratio0.70
Current Ratio9.55
Quick Ratio2.45


Trailing P/E Ratio10.97
Forward P/E Ratio7.24
P/E Growth0.41

Sales & Book Value

Annual Sales$2.58 billion
Price / Sales0.62
Cash Flow$2.6585 per share
Price / Cash Flow10.57
Book Value$25.09 per share
Price / Book1.12


EPS (Most Recent Fiscal Year)$2.58
Net Income$141.83 million
Net Margins6.21%
Return on Equity12.96%
Return on Assets6.71%


Outstanding Shares56,620,000
Market Cap$1.63 billion

M.D.C. (NYSE:MDC) Frequently Asked Questions

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. declared a quarterly dividend on Monday, October 22nd. Stockholders of record on Wednesday, November 7th will be given a dividend of $0.30 per share on Wednesday, November 21st. This represents a $1.20 dividend on an annualized basis and a dividend yield of 4.27%. The ex-dividend date of this dividend is Tuesday, November 6th. View M.D.C.'s Dividend History.

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) announced its earnings results on Thursday, November, 1st. The construction company reported $0.93 EPS for the quarter, missing analysts' consensus estimates of $0.95 by $0.02. The construction company earned $766.03 million during the quarter, compared to analyst estimates of $778.62 million. M.D.C. had a net margin of 6.21% and a return on equity of 12.96%. The firm's revenue for the quarter was up 30.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.07 earnings per share. View M.D.C.'s Earnings History.

When is M.D.C.'s next earnings date?

M.D.C. is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for M.D.C..

What price target have analysts set for MDC?

7 brokerages have issued twelve-month price targets for M.D.C.'s stock. Their forecasts range from $31.00 to $39.00. On average, they anticipate M.D.C.'s share price to reach $33.8333 in the next twelve months. This suggests a possible upside of 20.4% from the stock's current price. View Analyst Price Targets for M.D.C..

What is the consensus analysts' recommendation for M.D.C.?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for M.D.C..

Has M.D.C. been receiving favorable news coverage?

Media stories about MDC stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. M.D.C. earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave press coverage about the construction company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days.

Who are some of M.D.C.'s key competitors?

Who are M.D.C.'s key executives?

M.D.C.'s management team includes the folowing people:
  • Mr. Larry A. Mizel, Chairman & CEO (Age 75)
  • Mr. David D. Mandarich, Pres, COO & Director (Age 70)
  • Mr. Robert Nathaniel Martin, Sr. VP, CFO & Principal Accounting Officer (Age 39)
  • Mr. Michael Touff, Sr. VP & Gen. Counsel (Age 73)
  • Mr. Kelly Taga, Chief Information Officer & VP

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.10%), Vanguard Group Inc. (9.55%), Dimensional Fund Advisors LP (8.38%), LSV Asset Management (3.92%), Hamlin Capital Management LLC (3.24%) and Bank of New York Mellon Corp (2.06%). Company insiders that own M.D.C. stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Michael A Berman, Michael Touff and Robert Nathaniel Martin. View Institutional Ownership Trends for M.D.C..

Which major investors are selling M.D.C. stock?

MDC stock was sold by a variety of institutional investors in the last quarter, including Brandes Investment Partners LP, Allianz Asset Management GmbH, Hamlin Capital Management LLC, New England Research & Management Inc., AQR Capital Management LLC, Bridgeway Capital Management Inc., Russell Investments Group Ltd. and Credit Suisse AG. Company insiders that have sold M.D.C. company stock in the last year include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Larry A Mizel, Michael A Berman and Robert Nathaniel Martin. View Insider Buying and Selling for M.D.C..

Which major investors are buying M.D.C. stock?

MDC stock was bought by a variety of institutional investors in the last quarter, including Walthausen & Co. LLC, Heartland Advisors Inc., Artemis Investment Management LLP, Smith Graham & Co. Investment Advisors LP, Wells Fargo & Company MN, Vanguard Group Inc., Morgan Stanley and BlackRock Inc.. View Insider Buying and Selling for M.D.C..

How do I buy shares of M.D.C.?

Shares of MDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $28.10.

How big of a company is M.D.C.?

M.D.C. has a market capitalization of $1.63 billion and generates $2.58 billion in revenue each year. The construction company earns $141.83 million in net income (profit) each year or $2.58 on an earnings per share basis. M.D.C. employs 1,491 workers across the globe.

What is M.D.C.'s official website?

The official website for M.D.C. is http://www.mdcholdings.com.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The construction company can be reached via phone at 303-773-1100 or via email at [email protected]

MarketBeat Community Rating for M.D.C. (NYSE MDC)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  228 (Vote Outperform)
Underperform Votes:  356 (Vote Underperform)
Total Votes:  584
MarketBeat's community ratings are surveys of what our community members think about M.D.C. and other stocks. Vote "Outperform" if you believe MDC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel